FreeCME

Stage IV Melanoma: Strategies to Support Shared Decision Making

CME: 1.5

June 2, 2022
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

This activity is intended for oncology care providers (including physicians, advanced practice providers, nurses, and other HCPs) who care for patients with melanoma.

Program Overview

The explosion of therapeutic options for Stage IV disease has heralded improved outcomes for patients with Stage IV melanoma. However, this expanded array of available options brings increased complexity for decision making. This activity, Stage IV Melanoma: Strategies to Support Shared Decision Making, uses cases to illustrate state-of-the art management of Stage IV melanoma, with a particular emphasis on how to use the AIM at MelanomaStage IV melanoma decision-making support tool and Patient Action Plans to support shared decision making. The faculty will also illustrate effective communication strategies in these case simulations. Multidisciplinary approaches will be encouraged, addressing strategies to provide consistent education and engagement across the oncology care team.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the factors to consider in promoting shared decision making for stage IV melanoma
  • Compare and contrast the efficacy and safety of different therapies for stage IV melanoma
  • Incorporate shared decision-making approaches in different stage IV melanoma clinical scenarios

Faculty

Post a comment to this article